{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T14:08:57Z","timestamp":1743084537547,"version":"3.40.3"},"publisher-location":"Cham","reference-count":51,"publisher":"Springer Nature Switzerland","isbn-type":[{"type":"print","value":"9783031693434"},{"type":"electronic","value":"9783031693441"}],"license":[{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-3-031-69344-1_22","type":"book-chapter","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T08:03:29Z","timestamp":1729584209000},"page":"295-308","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Using the National Integrated Specimen Referral Network as a Vehicle to Reach the 3rd 95 in Nigeria in FY22"],"prefix":"10.1007","author":[{"given":"Faruna","family":"Theophilus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekeh","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Obianeri","family":"Victor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omolara","family":"Emmanuel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitris","family":"Folinas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,23]]},"reference":[{"key":"22_CR1","unstructured":"ASLM. http:\/\/www.aslm.org\/resource-centre\/hiv-viral-load-testing\/aids-2016-aslm-satellite-session-scaling%E2%80%90up-access-to-hiv-viral-load-testing\/. AIDS 2016 ASLM Satellite Session: Scaling-up Access to HIV Viral Load Testing \u2013 20 July 2016. Accessed 25 Jan 2024"},{"issue":"1","key":"22_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.omega.2014.05.009","volume":"49","author":"A Aguezzoul","year":"2014","unstructured":"Aguezzoul, A.: Third-party logistics selection problem: a literature review on criteria and methods. Omega 49(1), 69\u201378 (2014)","journal-title":"Omega"},{"issue":"1","key":"22_CR3","first-page":"1776946","volume":"6","author":"OI Akintoyese","year":"2020","unstructured":"Akintoyese, O.I., Olusegun, O.J., Albert, A.O., Joseph, O.E., Rasak, B.: Advancing alternative health care financing through effective community partnership: a necessity for universal health coverage in Nigeria. Cogent Soc. Sci. 6(1), 1776946 (2020)","journal-title":"Cogent Soc. Sci."},{"issue":"3","key":"22_CR4","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s44197-023-00097-1","volume":"13","author":"SA Awaidy","year":"2023","unstructured":"Awaidy, S.A., Ghazy, R.M., Mahomed, O.: Progress of the Gulf Cooperation Council (GCC) countries towards achieving the 95\u201395-95 UNAIDS targets: a review. J. Epidemiol. Glob. Health 13(3), 397\u2013406 (2023)","journal-title":"J. Epidemiol. Glob. Health"},{"issue":"4","key":"22_CR5","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.sjbs.2016.03.006","volume":"25","author":"AA Awofala","year":"2018","unstructured":"Awofala, A.A., Ogundele, O.E.: HIV epidemiology in Nigeria. Saudi J. Biol. Sci. 25(4), 697\u2013703 (2018)","journal-title":"Saudi J. Biol. Sci."},{"issue":"2010","key":"22_CR6","first-page":"166","volume":"19","author":"AS Balogun","year":"2014","unstructured":"Balogun, A.S.: HIV\/AIDS epidemic in the history of Nigeria, 1986\u20132007. J. Hist. Soc. Nigeria 19(2010), 166\u2013176 (2014)","journal-title":"J. Hist. Soc. Nigeria"},{"issue":"1","key":"22_CR7","doi-asserted-by":"publisher","first-page":"2271708","DOI":"10.1080\/16549716.2023.2271708","volume":"16","author":"DS Boakye","year":"2023","unstructured":"Boakye, D.S., Adjorlolo, S.: Achieving the UNAIDS 95-95-95 treatment target by 2025 in Ghana: a myth or a reality? Glob. Health Action 16(1), 2271708 (2023)","journal-title":"Glob. Health Action"},{"key":"22_CR8","doi-asserted-by":"crossref","unstructured":"Boyd, A.T., et al.: Expanding access to HIV services during the COVID-19 pandemic\u2014Nigeria, 2020. AIDS Res. Ther. 18(1), 1\u20138 (2021)","DOI":"10.1186\/s12981-021-00385-5"},{"issue":"1","key":"22_CR9","first-page":"1","volume":"19","author":"T Cane","year":"2022","unstructured":"Cane, T.: Working with HIV today. J. Pract. Teach. Learn. 19(1), 1\u20132 (2022)","journal-title":"J. Pract. Teach. Learn."},{"key":"22_CR10","doi-asserted-by":"crossref","unstructured":"Dalhatu, I., et al.: Outcomes of Nigeria\u2019s HIV\/AIDS treatment program for patients initiated on antiretroviral treatment between 2004\u20132012. PloS One, 11(11), e0165528 (2017)","DOI":"10.1371\/journal.pone.0165528"},{"issue":"3","key":"22_CR11","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3201\/eid2403.171797","volume":"24","author":"RW Eisinger","year":"2018","unstructured":"Eisinger, R.W., Fauci, A.S.: Ending the HIV\/AIDS pandemic. Emerg. Infect. Dis. 24(3), 413 (2018)","journal-title":"Emerg. Infect. Dis."},{"key":"22_CR12","doi-asserted-by":"publisher","unstructured":"Eisinger, R.W., Dieffenbach C.W., Fauci, A.S.: HIV viral load and transmissibility of HIV infection: undetectable equals untransmittable. JAMA 321(5), 451\u2013452 (2019). https:\/\/doi.org\/10.1001\/jama.2018.21167","DOI":"10.1001\/jama.2018.21167"},{"key":"22_CR13","doi-asserted-by":"publisher","unstructured":"Entonu, P.E., Agwale, S.M.: A review of the epidemiology, prevention, and treatment of Human Immunodeficiency Virus in Nigeria. Braz. J. Infect. Dis. 11(6), 579\u2013590 (2007). https:\/\/doi.org\/10.1590\/S1413-86702007000600011","DOI":"10.1590\/S1413-86702007000600011"},{"key":"22_CR14","first-page":"63","volume":"12","author":"P Evangelista","year":"2014","unstructured":"Evangelista, P.: Environmental sustainability practices in the transport and logistics service industry: an exploratory case study investigation. Res. Transp. Bus. Manag. 12, 63\u201372 (2014)","journal-title":"Res. Transp. Bus. Manag."},{"key":"22_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.omega.2013.08.006","volume":"45","author":"RZ Farahani","year":"2014","unstructured":"Farahani, R.Z., Rezapour, S., Drezner, T., Fallah, S.: Competitive supply chain network design: an overview of classifications, models, solution techniques and applications. Omega 45, 92\u2013118 (2014)","journal-title":"Omega"},{"issue":"7","key":"22_CR16","first-page":"8","volume":"8","author":"T Faruna","year":"2019","unstructured":"Faruna, T., Akintunde, E., Odelola, B.: Leveraging private sector transportation\/logistics services to improve Nigeria\u2019s National Integrated Specimen Referral Network. Bus. Manag. Dyn. 8(7), 8\u201316 (2019)","journal-title":"Bus. Manag. Dyn."},{"issue":"16","key":"22_CR17","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1001\/jama.2017.13505","volume":"318","author":"AS Fauci","year":"2017","unstructured":"Fauci, A.S.: An HIV vaccine is essential for ending the HIV\/AIDS pandemic. JAMA 318(16), 1535\u20131536 (2017)","journal-title":"JAMA"},{"issue":"23","key":"22_CR18","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1056\/NEJMp1502020","volume":"373","author":"AS Fauci","year":"2015","unstructured":"Fauci, A.S., Marston, H.D.: Ending the HIV\u2013AIDS pandemic\u2014follow the Science. N. Engl. J. Med. 373(23), 2197\u20132199 (2015)","journal-title":"N. Engl. J. Med."},{"key":"22_CR19","unstructured":"FMOH. Integrated National Guidelines for HIV Prevention Treatment and Care. In: National AIDS\/STIs Control Programme, editor. Abuja: FMOH, Abuja (2014)"},{"issue":"8","key":"22_CR20","doi-asserted-by":"publisher","first-page":"e0272405","DOI":"10.1371\/journal.pone.0272405","volume":"17","author":"L Frescura","year":"2022","unstructured":"Frescura, L., et al.: Achieving the 95 95 95 targets for all: a pathway to ending AIDS. PLoS ONE 17(8), e0272405 (2022). https:\/\/doi.org\/10.1371\/journal.pone.0272405","journal-title":"PLoS ONE"},{"key":"22_CR21","unstructured":"HEFDC (2020). https:\/\/hefdcgroup.com\/. National Integrated Specimen Referral Network Evaluation: hefdcgroup.com. Accessed 18 Jan 2024"},{"key":"22_CR22","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS): Country fact sheet: HIV and AIDS estimates. Geneva: UNAIDS (2020)"},{"key":"22_CR23","doi-asserted-by":"crossref","unstructured":"Joloba, M., et al.: Strengthening the tuberculosis specimen referral network in Uganda: the role of public-private partnerships. J. Infectious Dis. 213(suppl_2), S41\u2013S46 (2016)","DOI":"10.1093\/infdis\/jiw035"},{"key":"22_CR24","doi-asserted-by":"crossref","unstructured":"Kebede, Y., et al.: Improved specimen-referral system and increased access to quality laboratory services in Ethiopia: the role of the public-private partnership. J. Infectious Dis. 213(suppl_2), S59\u2013S64 (2016)","DOI":"10.1093\/infdis\/jiv576"},{"key":"22_CR25","doi-asserted-by":"crossref","unstructured":"Kiyaga, C., et al.: Uganda\u2019s new national laboratory sample transport system: a successful model for improving access to diagnostic services for early infant HIV diagnosis and other programs. PLoS One, 8(11), e78609 (2013)","DOI":"10.1371\/journal.pone.0078609"},{"issue":"1","key":"22_CR26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/jscm.12046","volume":"50","author":"R Leuschner","year":"2014","unstructured":"Leuschner, R., Carter, C.R., Goldsby, T.J., Rogers, Z.S.: Third-party logistics: a meta-analytic review and investigation of its impact on performance. J. Supply Chain Manag. 50(1), 21\u201343 (2014)","journal-title":"J. Supply Chain Manag."},{"key":"22_CR27","doi-asserted-by":"crossref","unstructured":"Louis, F.J., et al.: Specimen referral network to rapidly scale up CD4 testing: the hub and spoke model for Haiti. J. AIDS & Clin. Res. 6(8), 1000488 (2015)","DOI":"10.4172\/2155-6113.1000488"},{"issue":"29","key":"22_CR28","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1016\/j.vaccine.2015.03.042","volume":"33","author":"P Lydon","year":"2015","unstructured":"Lydon, P., Raubenheimer, T., Arnot-Kr\u00fcger, M., Zaffran, M.: Outsourcing vaccine logistics to the private sector: the evidence and lessons learned from the Western Cape Province in South Africa. Vaccine 33(29), 3429\u20133434 (2015)","journal-title":"Vaccine"},{"issue":"2","key":"22_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2307\/20713632","volume":"45","author":"MJ Maloni","year":"2006","unstructured":"Maloni, M.J., Carter, C.R.: Opportunities for research in third-party logistics. Transp. J. 45(2), 23\u201338 (2006)","journal-title":"Transp. J."},{"key":"22_CR30","unstructured":"NACA. https:\/\/naca.gov.ng\/nigeria-prevalence-rate\/ Nigeria prevalence rates. Accessed 07 Sept 2023"},{"key":"22_CR31","unstructured":"National Agency for the Control of AIDS (NACA). https:\/\/naca.gov.ng\/anti-retroviral-therapy, Antiretroviral Therapy. Accessed 15 Oct 2023"},{"issue":"1","key":"22_CR32","first-page":"221","volume":"4","author":"SAJ Obansa","year":"2013","unstructured":"Obansa, S.A.J., Orimisan, A.: Health care financing in Nigeria: prospects and challenges. Mediterr. J. Soc. Sci. 4(1), 221\u2013236 (2013)","journal-title":"Mediterr. J. Soc. Sci."},{"issue":"3","key":"22_CR33","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/09709274.2012.11906461","volume":"37","author":"BI Ofem","year":"2012","unstructured":"Ofem, B.I.: A review of the criteria for defining urban areas in Nigeria. J. Hum. Ecol. 37(3), 167\u2013171 (2012)","journal-title":"J. Hum. Ecol."},{"key":"22_CR34","doi-asserted-by":"crossref","unstructured":"Okoroiwu, H.U., et al.: Thirty-five years (1986\u20132021) of HIV\/AIDS in Nigeria: bibliometric and scoping analysis. AIDS Res. Ther. 19(1), 1\u201315 (2022)","DOI":"10.1186\/s12981-022-00489-6"},{"issue":"1","key":"22_CR35","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4103\/0331-3131.100199","volume":"6","author":"BO Olakunde","year":"2012","unstructured":"Olakunde, B.O.: Public health care financing in Nigeria: which way forward. Ann. Nigerian Med. 6(1), 4 (2012)","journal-title":"Ann. Nigerian Med."},{"issue":"5","key":"22_CR36","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.aogh.2015.10.005","volume":"81","author":"BO Olakunde","year":"2015","unstructured":"Olakunde, B.O., Ndukwe, C.D.: Improved domestic funding enhances the sustainability of the HIV\/AIDS response in Nigeria. Ann. Glob. Health 81(5), 684\u2013688 (2015)","journal-title":"Ann. Glob. Health"},{"key":"22_CR37","doi-asserted-by":"publisher","unstructured":"Onovo, A.A., et al.: Estimation of HIV prevalence and burden in Nigeria: a Bayesian predictive modeling study. E Clin. Med. 62, 102098 (2023). https:\/\/doi.org\/10.1016\/j.eclinm.2023.102098. PMID: 37538543; PMCID: PMC10393599","DOI":"10.1016\/j.eclinm.2023.102098"},{"key":"22_CR38","doi-asserted-by":"crossref","unstructured":"Rangarajan, S., et al.: Factors associated with HIV viral load suppression on antiretroviral therapy in Vietnam. J. Virus Eradication 2(2), 94\u2013101 (2016)","DOI":"10.1016\/S2055-6640(20)30466-0"},{"key":"22_CR39","unstructured":"Sangadi, G.E., Muhereza, A., Aloyo, J., Karamagi, E., Rahimzai, M.: Addressing the 3rd 90 gaps through integrated health delivery camps in 4 health facilities in Nwoya District Uganda (2017). https:\/\/www.popline.org\/node\/666978. Accessed 01 Nov 2023"},{"issue":"419","key":"22_CR40","first-page":"1","volume":"19","author":"MB Shiferaw","year":"2019","unstructured":"Shiferaw, M.B., et al.: Viral suppression rate among children tested for HIV viral load at the Amhara Public Health Institute, Bahir Dar Ethiopia. BMC Infectious Dis. 19(419), 1\u20136 (2019)","journal-title":"BMC Infectious Dis."},{"key":"22_CR41","volume-title":"Managing the Supply Chain: The Definitive Guide for the Business Professional","author":"D Simchi-Levi","year":"2004","unstructured":"Simchi-Levi, D., Kaminsky, P.: Managing the Supply Chain: The Definitive Guide for the Business Professional. Irwin McGraw-Hill, Boston (2004)"},{"key":"22_CR42","unstructured":"The Nigeria US Embassy. https:\/\/ng.usembassy.gov\/pepfar\/. Accessed 09 Jan 2024"},{"key":"22_CR43","unstructured":"UNAIDS (n.d.). What is World AIDS Day? https:\/\/www.unaids.org\/en\/World_AIDS_Day. Accessed 7 Sept 2023"},{"key":"22_CR44","unstructured":"UNAIDS (2014) UNAIDS. 95-95-95 An Ambitious Treatment Target to help end the AIDS epidemic. Geneva, Switzerland 2020. https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/201506_JC2743_Understanding_FastTrack_en.pdf"},{"key":"22_CR45","unstructured":"UNAIDS (2020) UNAIDS. 95-95-95 An Ambitious Treatment Target to help end the AIDS epidemic. Geneva, Switzerland 2020. https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/201506_JC2743_Understanding_FastTrack_en.pdf"},{"key":"22_CR46","unstructured":"United Nations: Transforming our world: the 2030 Agenda for Sustainable Development. Accessed 9 Jan 2024"},{"issue":"3","key":"22_CR47","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s10393-014-0980-5","volume":"12","author":"J Voyles","year":"2015","unstructured":"Voyles, J., et al.: Moving beyond too little, too late: managing emerging infectious diseases in wild populations requires international policy and partnerships. EcoHealth 12(3), 404\u2013407 (2015)","journal-title":"EcoHealth"},{"key":"22_CR48","unstructured":"World Health Organization. Scaling up antiretroviral therapy in resource-limited settings (2003 REVISION), pp. 9\u201310. WHO, Geneva (2004)"},{"key":"22_CR49","unstructured":"World Health Organization (2016). https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/208825\/97892?sequence=1 Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Accessed 25 Aug 2023"},{"key":"22_CR50","unstructured":"World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. World Health Organization (2016). https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/208825\/97892?sequence=1"},{"key":"22_CR51","unstructured":"Zwetyenga, J.S.L.G., et al.: Laboratory core capacities to be improved in two Central Asian countries through addressing national sample referral mechanisms. PANORAMA 23(1), 4\u20137 (2018)"}],"container-title":["Communications in Computer and Information Science","Supply Chains"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-69344-1_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T08:13:21Z","timestamp":1729584801000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-69344-1_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,23]]},"ISBN":["9783031693434","9783031693441"],"references-count":51,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-69344-1_22","relation":{},"ISSN":["1865-0929","1865-0937"],"issn-type":[{"type":"print","value":"1865-0929"},{"type":"electronic","value":"1865-0937"}],"subject":[],"published":{"date-parts":[[2024,10,23]]},"assertion":[{"value":"23 October 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"The opinions and findings in this research are the author\u2019s own, and they may not necessarily reflect those of the USAID or GHSC-PSM. This work has no financial inducement or support from anywhere and is with no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interests and Financial Support"}},{"value":"ICSC","order":1,"name":"conference_acronym","label":"Conference Acronym","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Olympus International Conference on Supply Chains","order":2,"name":"conference_name","label":"Conference Name","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Katerini","order":3,"name":"conference_city","label":"Conference City","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Greece","order":4,"name":"conference_country","label":"Conference Country","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"2024","order":5,"name":"conference_year","label":"Conference Year","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"23 May 2024","order":7,"name":"conference_start_date","label":"Conference Start Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"25 May 2024","order":8,"name":"conference_end_date","label":"Conference End Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"oicsc2024","order":10,"name":"conference_id","label":"Conference ID","group":{"name":"ConferenceInfo","label":"Conference Information"}}]}}